文献速递脑血管病

儿童急性缺血性卒中的血管内取栓治疗

Endovascular Thrombectomy for Pediatric Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2022-03-11

基于美国全国住院患者样本2010至2019年加权出院数据,共识别7365例儿童缺血性卒中患者,其中190例(2.6%)接受血管内取栓治疗。取栓使用率在取栓临床试验后时代(2016-2019年)显著增加(1.7% vs 4.0%,P<0.001),去骨瓣减压术使用减少(2.8% vs 0.7%,P<0.001)。倾向性校正后,取栓组与药物治疗组有利功能结局率无显著差异(55.3% vs 52.8%,P=0.830;不利结局校正风险比1.01[95%CI 0.51-2.03],P=0.972)。作者认为取栓可能是安全的方式,并带来较高的有利功能结局率。

要点

  • 儿童缺血性卒中取栓使用率从2016年前1.7%升至2016-2019年4.0%(P<0.001)。
  • 取栓组55.3%达有利功能结局,未报告围术期医源性并发症或对比剂肾病。
  • 倾向校正后取栓组与药物组有利结局率无显著差异(55.3% vs 52.8%,P=0.830)。

核心结论

  • 作者认为血管内取栓可能是安全的方式,并带来较高的有利功能结局率。

研究设计与样本

  • 横断面评估,查询美国全国住院患者样本2010至2019年加权出院数据,识别年龄小于18岁的儿童缺血性卒中患者。
  • 采用复杂抽样统计方法描述取栓治疗患者的特征与临床结局,并按基线特征差异进行倾向性校正以处理取栓适应证的混杂。

主要发现

  • 共识别7365例儿童缺血性卒中患者,其中190例(2.6%)接受血管内取栓治疗。
  • 取栓使用率在取栓临床试验后时代(2016-2019年)显著增加(1.7% vs 4.0%,P<0.001),去骨瓣减压术使用减少(2.8% vs 0.7%,P<0.001)。
  • 未校正分析中,105例(55.3%)取栓治疗患者出院时达到有利功能结局(回家或转至急性康复机构),未报告围术期医源性并发症或对比剂肾损伤。
  • 倾向校正后,取栓治疗患者有利功能结局率绝对值较高但无统计学意义(55.3% vs 52.8%,P=0.830;不利结局校正风险比1.01[95%CI 0.51-2.03],P=0.972)。
  • 基线美国国立卫生研究院卒中量表评分大于11分(队列评分第75百分位)的患者中,取栓治疗患者有利功能结局率有高于仅药物治疗患者的趋势(71.4% vs 55.6%,P=0.146)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence regarding the utilization and outcomes of endovascular thrombectomy (EVT) for pediatric ischemic stroke is limited, and justification for its use is largely based on extrapolation from clinical benefits observed in adults. METHODS: Weighted discharge data from the National Inpatient Sample were queried to identify pediatric patients with ischemic stroke (<18 years old) during the period of 2010 to 2019. Complex samples statistical methods were used to characterize the profiles and clinical outcomes of EVT-treated patients. Propensity adjustment was performed to address confounding by indication for EVT based on disparities in baseline characteristics between EVT-treated patients and those medically managed. RESULTS: Among 7365 pediatric patients with ischemic stroke identified, 190 (2.6%) were treated with EVT. Utilization significantly increased in the post-EVT clinical trial era (2016-2019; 1.7% versus 4.0%; P<0.001), while the use of decompressive hemicraniectomy decreased (2.8% versus 0.7%; P<0.001). On unadjusted analysis, 105 (55.3%) EVT-treated patients achieved favorable functional outcomes at discharge (home or to acute rehabilitation), while no periprocedural iatrogenic complications or instances of contrast-induced kidney injury were reported. Following propensity adjustment, EVT-treated patients demonstrated higher absolute but nonsignificant rates of favorable functional outcomes in comparison with medically managed patients (55.3% versus 52.8%; P=0.830; adjusted hazard ratio, 1.01 [95% CI, 0.51-2.03]; P=0.972 for unfavorable outcome). Among patients with baseline National Institutes of Health Stroke Scale score >11 (75th percentile of scores in cohort), EVT-treated patients trended toward higher rates of favorable functional outcomes compared with those treated medically only (71.4% versus 55.6%; P=0.146). In a subcohort assessment of EVT-treated patients, those administered preceding thrombolytic therapy (n=79, 41.6%) trended toward higher rates of favorable functional outcomes (63.3% versus 49.5%; P=0.060). CONCLUSIONS: This cross-sectional evaluation of the clinical course and short-term outcomes of pediatric patients with ischemic stroke treated with EVT demonstrates that EVT is likely a safe modality which confers high rates of favorable functional outcomes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Dicpinigaitis AJ, Gandhi CD, Pisapia J, et al. Endovascular Thrombectomy for Pediatric Acute Ischemic Stroke. Stroke. 2022. PMID: 35272483. doi:10.1161/STROKEAHA.121.036361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。